CT Automotive Group plc (CTA) — Investment research note

Executive summary

CT Automotive is a UK-headquartered, AIM-listed designer and manufacturer of bespoke automotive interior components (dashboard panels, kinematic assemblies) supplying 21 OEMs from low-cost facilities in China, Mexico and Türkiye. Across FY22–FY25 the group rebuilt margins aggressively (gross margin 12% → 31%) while revenue normalised post-Covid and OEMs destocked, delivering three consecutive years of improved adjusted PBT despite stagnant top-line. The single most important point for valuation is that the shares trade on roughly 4x trailing earnings with $47m of contracted new business ramping into FY27, while the FY25 results disclosed a $5.0m net-asset prior-period restatement and the CFO has just resigned — a quality discount is warranted, but the multiple suggests it is already there.

Fair value estimate

Methodology: earnings multiple cross-checked with EV/EBITDA, given the small cap and limited DCF visibility.

• FY25 reported PBT $9.1m → ~$7.4m net (assumed 18% effective tax on a partially sheltered base) → ~£5.8m at $1.27 → basic EPS ~10p (vs 11.4c reported = ~9p sterling).
• Adjusted EBITDA $14.8m → ~£11.7m. EV at current price = £26.5m mcap + ~£6.1m net debt (excl. IFRS 16) = ~£32.6m → EV/EBITDA ~2.8x.
• UK auto-supplier comparables typically trade at 6–9x trailing earnings / 4–5x EV/EBITDA. Applying a meaningful quality discount for AIM size, customer concentration (top-3 = 77% of revenue 2026-05 final results), China/Türkiye exposure, the recent prior-period restatement and CFO departure, a fair range of 5.5–7.5x earnings looks defensible.
• Fair value per share: 50p – 70p, equating to a fair-value market cap of £37m – £52m (mid ~£44m).
• Upside vs. 36p / £26.5m mcap: +39% to +94%, midpoint ~+67%.

The cheapness is not subtle — the question is whether earnings power is real, not whether the multiple is low.

Sector context

• Sector classification confirmed: Consumer Discretionary / Automobiles & Parts (ICB).
• Quality/growth/leverage profile is below typical larger-cap auto suppliers — micro-cap, AIM-listed, AIM-quality disclosure, customer-concentrated and exposed to tariff/geopolitical shocks. Balance sheet leverage, however, is more modest than peers (net debt ~0.5x EBITDA).
• Listed peer comparators: Forvia (FORVIA SE), Adient plc, Marelli (private, in Chapter 11) — though all multiples of CTA's size and global reach. UK-listed AIM micro-cap peers (TI Fluid Systems on Main Market, prior to take-private) trade at 4–7x earnings.

Investment thesis

1. Self-help margin story has worked and looks durable. Gross margin expanded from 22% to 28% to 31% across FY23→FY25 via automation, plant consolidation (China → Ganzhou), and overhead reduction; FY26 should benefit from a full year of the Mexico ramp at target efficiency 2026-05 final results. With $47m of annualised new-business wins (15 contracts) ramping into FY27 against an essentially fixed Mexico cost base, incremental drop-through should be material.
2. Mexico tariff-shelter optionality is real, not press-release noise. Three customer programs were transferred to Mexico in Q1 2025 specifically to avoid US tariffs, and four H1 2025 wins came from competitors losing programs to CT Mexico 2025-09 half-year. Mexico facility was expanded with $5.6m of capex in FY25; this is a tangible competitive moment, not a slide-deck pitch.
3. Valuation is undemanding and balance sheet is supportive. At 36p the shares trade at ~4x reported earnings and ~2.8x EV/EBITDA, with net debt only 0.5x EBITDA and FCCR comfortably at 1.83x vs. 1.5x covenant 2026-05 final results. The investor does not need to believe heroic things to make money — they need the business to merely keep delivering.

Key risks

1. Accounting restatement / governance overhang. FY25 results restated FY24 net assets down by $5.0m and FY24 adjusted PBT down by $0.8m across five categories of error stretching back to 2021, including IFRS 16 lease consolidation mistakes that required an external Rebus Partners review 2026-05 final results. The CFO resigned in early 2026 and has not been replaced — finance is being run by the Group Head of Finance reporting to the Audit Chair. This is a material earnings-quality flag in a microcap.
2. Customer concentration and Tier-1 fragility. Top three customers = 45% + 21% + 11% = 77% of FY25 revenue 2026-05 final results. Marelli (one of those Tier-1s) is in Chapter 11 and CTA has continued supplying through the process, absorbing some working-capital tension. Any single OEM/Tier-1 program-loss or further customer distress would materially shift the picture.
3. Cyclical end-market and tariff/geopolitical risk. Auto production is cyclical; FY25 already saw OEM destocking, Chinese OEMs taking share in Europe, and EV launch delays. CTA's manufacturing footprint is in China, Mexico and Türkiye — each has its own tariff/inflation/wage exposure (Türkiye hyperinflation, China tariffs, Mexico USMCA risk). Tariff escalation clauses are passed on with a lag, not always in full 2026-05 final results.

Operating leverage

This is not a software business but it does have observable operating leverage from its current scale point. Group revenue of $115m generates gross profit of $35m (31% gross margin) and adjusted EBITDA of $14.8m (13% margin), so the gross-to-EBITDA bridge — roughly $20m of admin and distribution expense — is the dollar value of the semi-fixed cost base. Management states facilities retain "additional capacity to support future growth without requiring significant additional capital investment" 2026-05 final results. The $47m of contracted new-business wins arriving by FY28 represents ~40% revenue uplift on FY25, and if gross margin holds at 31% the incremental gross profit is ~$14.5m, against which only modest admin/distribution growth would be needed — plausibly $4–6m of overhead absorption, leaving $8–10m of incremental adjusted EBITDA. That would roughly double current adjusted EBITDA, consistent with a "moderate-to-strong" operating leverage profile (high-50s on the 0–100 scale). Caveat: tooling revenue is genuinely high-margin (~30%+ gross) but lumpy; serial production is closer to commodity manufacturing economics.

Value-trap signals

• Prior-period accounting misstatements across multiple years ($5.0m net asset reduction, restatements spanning 2021–2024).
• CFO resignation in early 2026 with no permanent replacement named.
• Customer concentration (top 3 = 77% of revenue), with one (Marelli) in Chapter 11.
• Tooling revenue accounting has been a repeated source of historical errors (one tooling project caused $825k revenue overstatement in 2022, followed by mis-write-offs in 2023 and 2024).
• Related-party loan from CEO's wholly-owned company (Automotive Kinetic Systems Limited) to the Chinese subsidiary at 12.4% interest — small ($385k) but worth flagging.

Earnings vs. expectations

• FY25 (Feb 2026 trading update): Guidance/consensus going in was revenue $113m, adj PBT $10.5m. Delivered "at least $113m" revenue (in line) and "at least $10m" adj PBT (slight miss to consensus, beat to revised guidance). Actual final results came in at $114.8m revenue / $9.5m adj PBT — a small miss vs. Feb update, partly absorbed by Mexico launch costs and a stock-valuation adjustment 2026-05 final results; 2026-02 trading statement.
• H1 2025 (Sep 2025): Revenue $54.1m vs consensus implying ~$60m+ — soft on revenue, profitability in line; full-year revenue guidance lowered while PBT held.
• FY24: Revenue $119.7m vs consensus expectation $119.1m (in line); adj PBT $8.7m vs expectation $9.3m (modest miss).
• FY23: Recovery year, ahead of expectations on revenue ($133m vs ~$130m guided in February trading update).

Pattern: Mixed — broadly in-line to small misses, no large beats and no large blow-ups, but a clear tendency for revenue to disappoint while management protects profitability via cost actions. Earnings surprise score around 40–50 ("more misses than beats, by small amounts").

Conviction

Conviction: 3 (moderate).

Anchored by: (i) three years of demonstrated margin improvement that is visible in the numbers, not just narrative; (ii) the multiple is undemanding enough that a wide fair-value range still implies meaningful upside; (iii) the contracted new-business pipeline is a tangible forward driver, not a vague aspiration.

Limited by: (i) the prior-period restatement and CFO departure materially impair confidence in reported earnings power — the same business has been told three different stories about FY24 in 18 months; (ii) customer concentration plus Marelli Chapter 11 add a real tail-risk to any forward number.

Driver scoring rationale (summary)

• AI beneficiary (low): CTA uses AI internally for factory ops; it is not a recipient of AI capex. The mooted Factory Operating System might one day be sold externally but is speculative.
• Operating leverage (moderate-high): Mexico facility has spare capacity, fixed-cost base is largely set, $47m of incremental revenue should drop disproportionately.
• Cyclicality (high): Pure auto component supplier, deeply tied to OEM production schedules.
• Moat (low): Price-leader low-cost manufacturer with bespoke tooling switching costs — execution moat, not structural.
• Leverage (low): Net debt ~0.5x EBITDA, FCCR 1.83x.
• Earnings quality (poor-to-medium): Restatements, CFO exit, hyperinflation accounting noise — but cash generation is genuine.
• Management (medium): Operational execution good; financial governance weak.
• Growth (modest): Revenue declining near-term, but visible recovery and acceleration into FY27.